Quantcast

Latest Clinical trial Stories

2014-06-30 08:31:06

DUBLIN, June 30. 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/kzl2xt/clinical_trial) has announced the addition of the "2014 Report on the International Clinical Trial Management System Market - Forecast to 2019" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 Clinical trial management system (CTMS) is a software solution for proper management, storage and analysis of drugs associated clinical data. Globally, the CTMS...

2014-06-30 08:30:01

LUGANO, Switzerland, June 30, 2014 /PRNewswire/ -- Exclusive distribution and licensing agreement signed for the commercialization of Helsinn's compound currently in development for the treatment of cancer anorexia-cachexia syndrome in non-small cell lung cancer (NSCLC) patients Helsinn Group, the company focused on building quality cancer care, today announces that rights to anamorelin, its innovative ghrelin receptor agonist, have been granted in Turkey to GEN Ilac....

2014-06-27 21:43:11

BMJ-British Medical Journal US regulator has taken 84 sponsors/investigators/institutions to task over 7 years Failure to protect patient safety and poor record keeping were among the most common violations picked up by the US regulator in the running of clinical trials over a period of seven years, reveals a study published online in the Journal of Medical Ethics. The study authors reviewed the content of 84 first warning letters issued by the United States Food and Drug...

2014-06-27 08:25:47

LONDON and ROCHESTER, New York, June 27, 2014 /PRNewswire/ -- Commercial and Operational Alliance to Provide Clinical Trials Industry With Global Capabilities and a Full Range of Therapeutic Areas and Modality Expertise IXICO plc (Ticker: IXI) ("IXICO" or the "Company"), the brain health company, and VirtualScopics, Inc. (NASDAQ:VSCP), a leading provider of clinical trial imaging solutions, today said they have signed an Alliance Framework Agreement and...

2014-06-27 04:21:21

ROCHESTER, N.Y. and LONDON, June 27, 2014 /PRNewswire/ -- VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of clinical trial imaging solutions, and IXICO plc (AIM: IXI), the brain health company, today said they have signed an Alliance Framework Agreement and Master Subcontractor Agreement previously announced as an agreement in principle on March 7, 2014. This alliance will provide the clinical trials industry with global operational capabilities and a full range of...

2014-06-26 23:10:35

David Turner to discuss mobile solutions for clinical trials at the Digital Health Zone App Bar on June 26, 2014 San Diego, CA (PRWEB) June 26, 2014 Parallel 6 makes its introduction as a clinical trial mobile solution at this week’s 2014 BIO International Convention. Parallel 6 CEO David Turner will speak on June 26, 2014 demonstrating the mobile enterprise platform Captive Reach and its influence on the future of clinical trials. “At Parallel 6, our Captive Reach platform and...

2014-06-26 16:23:38

Paper Addresses Challenges and Explores Opportunities to Stimulate Repurposing of FDA-Approved Drugs for Alzheimer's, Parkinson's and Related Diseases NEW YORK, June 26, 2014 /PRNewswire-USNewswire/ -- A new peer-reviewed publication from the Alzheimer's Drug Discovery Foundation (ADDF) and The Michael J. Fox Foundation for Parkinson's Research (MJFF) offers strategic insight on how philanthropy, industry and government organizations can advance repurposing of U.S. Food and Drug...

2014-06-26 08:28:23

-Contributions advancing AD clinical trials to be highlighted in a series of diverse presentations- NEWTOWN, Pa., June 26, 2014 /PRNewswire/ -- BioClinica(®), Inc., the world's leading provider of medical imaging and cardiovascular safety services for the pharmaceutical, biotechnology, and medical device industries, announced today that their neuroscience clinical trial experts will present recent clinical trial progress on the front against Alzheimer's Disease (AD) at this year's...

2014-06-25 23:09:12

This webinar will describe the Translational Pharmaceutics™ platform and present Enabled-First-in-Human case studies to illustrate how it has been applied in early stage drug development programs. There will be two live broadcasts on Wednesday July 9, 2014, at 9am EDT/2pm BST, and at 12pm EDT/5pm BST. Toronto, Canada (PRWEB) June 25, 2014 Enabled-First-in-Human™ programs re-engineer the pathway from candidate selection into clinical development and through to Proof of Concept (PoC)....

2014-06-25 08:30:55

GREENWOOD VILLAGE, Colo., June 25, 2014 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced that it has informed the Transplant and Ophthalmology Division of the FDA of its intent to reduce the patient sample size in the OptimEyes Study for the treatment of Diabetic Macular Edema (oral treatment with Optina(TM)). This trial was intended to enroll 450 patients and was powered at 95%. The present enrollment of over 355 patients provides an adequate power of 88%,...


Word of the Day
siliqua
  • A Roman unit of weight, 1⁄1728 of a pound.
  • A weight of four grains used in weighing gold and precious stones; a carat.
  • In anatomy, a formation suggesting a husk or pod.
  • The lowest unit in the Roman coinage, the twenty-fourth part of a solidus.
  • A coin of base silver of the Gothic and Lombard kings of Italy.
'Siliqua' comes from a Latin word meaning 'a pod.'
Related